| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Tempest Therapeutics, Inc. | Corporate Controller | Common Stock | 22,168 | $47,883 | $2.16 | 28 Jun 2024 | Direct |
| Tempest Therapeutics, Inc. | Corporate Controller | Employee Stock Option (right to buy) | 30,000 | 02 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TPST | Tempest Therapeutics, Inc. | 02 Jan 2025 | 1 | $0 | 4 | Corporate Controller | 06 Jan 2025, 17:00 |
| TPST | Tempest Therapeutics, Inc. | 28 Jun 2024 | 1 | +$16,200 | 4 | Corporate Controller | 02 Jul 2024, 16:15 |
| TPST | Tempest Therapeutics, Inc. | 03 Jan 2024 | 1 | $0 | 4 | Principal Accounting Officer | 05 Jan 2024, 16:39 |
| TPST | Tempest Therapeutics, Inc. | 11 Oct 2023 | 1 | $0 | 4 | Corporate Controller | 13 Oct 2023, 16:39 |
| TPST | Tempest Therapeutics, Inc. | 03 Jan 2023 | 1 | $0 | 4 | Corporate Controller | 05 Jan 2023, 18:57 |
| TPST | Tempest Therapeutics, Inc. | 03 Oct 2022 | 1 | $0 | 4 | Corporate Controller | 04 Oct 2022, 08:01 |
| TPST | Tempest Therapeutics, Inc. | 30 Sep 2022 | 0 | $0 | 3 | Corporate Controller | 04 Oct 2022, 08:00 |